Oral bacteria as potential probiotics for the pharyngeal mucosa.
about
Streptococcus pyogenes biofilms-formation, biology, and clinical relevanceClinical and laboratory features of Streptococcus salivarius meningitis: a case report and literature review.Mechanistic model of Rothia mucilaginosa adaptation toward persistence in the CF lung, based on a genome reconstructed from metagenomic dataUse of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome.Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract.Sil: a Streptococcus iniae bacteriocin with dual role as an antimicrobial and an immunomodulator that inhibits innate immune response and promotes S. iniae infection.The vaginal isolate Lactobacillus paracasei LPC-S01 (DSM 26760) is suitable for oral administration.Investigation of Streptococcus salivarius-mediated inhibition of pneumococcal adherence to pharyngeal epithelial cellsEscherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein.Genome sequence of the lantibiotic bacteriocin producer Streptococcus salivarius strain K12.Health-Promoting Properties of Lactobacillus helveticus.S-layer protein mediates the stimulatory effect of Lactobacillus helveticus MIMLh5 on innate immunity.Protective mechanisms of respiratory tract Streptococci against Streptococcus pyogenes biofilm formation and epithelial cell infection.Bifidobacterium bifidum PRL2010 modulates the host innate immune response.A Novel Rhamnose-Rich Hetero-exopolysaccharide Isolated from Lactobacillus paracasei DG Activates THP-1 Human Monocytic Cells.Beneficial microbes for the oral cavity: time to harness the oral streptococci?The microbiome of the soft palate of swine.Developing oral probiotics from Streptococcus salivarius.Otitis media among high-risk populations: can probiotics inhibit Streptococcus pneumoniae colonisation and the risk of disease?Complete genome sequence of the commensal Streptococcus salivarius strain JIM8777.A Review of Probiotic Therapy in Preventive Dental Practice.Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens.A dairy bacterium displays in vitro probiotic properties for the pharyngeal mucosa by antagonizing group A streptococci and modulating the immune response.In vitro assessment of the ability of probiotics, blueberry and food carbohydrates to prevent S. pyogenes adhesion on pharyngeal epithelium and modulate immune responses.Three glycosylated serine-rich repeat proteins play a pivotal role in adhesion and colonization of the pioneer commensal bacterium, Streptococcus salivarius.Probiotic bacteria inhibit the bovine respiratory pathogen Mannheimia haemolytica serotype 1 in vitro.Probiotics in addition to antibiotics for the treatment of acute tonsillitis: a randomized, placebo-controlled study.Modulation of host responses by oral commensal bacteria.In vitro functional and immunomodulatory properties of the Lactobacillus helveticus MIMLh5-Streptococcus salivarius ST3 association that are relevant to the development of a pharyngeal probiotic product.Health-Associated Niche Inhabitants as Oral Probiotics: The Case of Streptococcus dentisani.Identification of New Factors Modulating Adhesion Abilities of the Pioneer Commensal Bacterium Streptococcus salivarius.Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis.
P2860
Q28387682-179D32A9-AC8B-4AD8-8826-575C5798F081Q30470322-AE487DC4-E2B5-429B-8E37-50EFBC7A959CQ30641042-6E075FEF-6D0C-4699-A0AA-86D9E3D7D0B6Q33650357-05420FE3-4728-4204-BA57-E270DB09CDF5Q34299362-E86DE6E6-2179-4573-8C31-B38A3DFD8A6EQ34387493-25EA6967-6A14-475F-BE19-8ECC6D42BA3CQ35159763-58520F13-CBBA-4619-B0A3-429338E77A86Q36059416-A2DE62FC-5AB2-45E2-A6ED-20F4A276BD17Q36146974-21C4BDC9-0183-4E21-B850-05CCBB5FA255Q36361827-C3FD5502-064A-4AB8-97B7-79924D640680Q36362689-A245D987-7B49-44A3-817B-3590B3D96D0DQ36407339-AD965D4A-6F69-41F8-BBAA-8E44F28C7D2AQ36599131-7F56AC4A-4BBD-444C-9243-619179CE38BDQ36599153-AFBFBCFB-23EC-40F8-B3D1-D27B5748DC20Q37545473-20AB6815-7302-4FBF-84DF-B5B4758B9B1CQ37593134-B7520326-DA71-47E2-9537-0548E1B11783Q37917289-4F1A9302-F84D-42CF-A24B-945265E47E6EQ38031316-2DA7C103-4234-4DF2-A219-1141DCF0F1CEQ38066574-66A202F3-4B49-4B76-BAAC-91B6449F756AQ38091357-D51995DA-40A5-411C-ABB1-0D583593ECCAQ38285597-D2628426-6725-4229-9184-C4F6C74BD4C2Q38701780-BC941913-4F23-44B3-87BB-6444FFE6976BQ39412693-3CBFC640-62C6-4B80-ADB5-EFD365AFAD29Q39664184-F6FB469B-6039-4A4B-BAF9-45E0C95594BCQ40054102-B54DF82F-FAAB-43C6-B205-86039EA7F4C0Q40140255-D5E0EA00-4E58-4E27-9708-E5F3E86E4A37Q40339885-FF20AC66-82C3-464D-B75D-E88141BD599BQ41524789-7E7CB22B-1452-4E05-A7DB-CBC8BB323947Q41945242-01F63C70-2A55-4170-9E8C-C20298CF1C8CQ42057955-6AF3EED6-552F-456C-930D-ACB3DEC233CBQ42317214-8C52CF00-0CF9-435E-B35C-97907D908FE3Q52668341-D668889A-54DC-4E50-98C4-DA493838DC6AQ55258128-91CB2F1E-94D6-440E-99B5-9175BAED3B3E
P2860
Oral bacteria as potential probiotics for the pharyngeal mucosa.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Oral bacteria as potential probiotics for the pharyngeal mucosa.
@en
type
label
Oral bacteria as potential probiotics for the pharyngeal mucosa.
@en
prefLabel
Oral bacteria as potential probiotics for the pharyngeal mucosa.
@en
P2093
P2860
P50
P356
P1476
Oral bacteria as potential probiotics for the pharyngeal mucosa
@en
P2093
Mario Minuzzo
Milda Stuknyte
Valentina Taverniti
P2860
P304
P356
10.1128/AEM.00109-10
P407
P577
2010-04-23T00:00:00Z